Apyx Medical Corporation (APYX) financial statements (2020 and earlier)
Company profile
| Business Address |
5115 ULMERTON ROAD CLEARWATER, FL 33760 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 59 | 78 | 10 | 14 | 12 | 6 | 8 | ||
| Cash and cash equivalents | 59 | 16 | 10 | 14 | 12 | 6 | 8 | ||
| Short-term investments | 62 | ||||||||
| Receivables | 9 | 5 | 5 | 5 | 3 | 2 | 2 | ||
| Inventory, net of allowances, customer advances and progress billings | 5 | 5 | 7 | 6 | 6 | 6 | 8 | ||
| Inventory | 5 | 5 | 7 | 6 | 6 | 6 | 8 | ||
| Deposits current assets | 0 | 1 | |||||||
| Other undisclosed current assets | 4 | 1 | 1 | 1 | 1 | 2 | 1 | ||
| Total current assets: | 77 | 90 | 23 | 27 | 22 | 15 | 20 | ||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset | 1 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Operating lease, right-of-use asset | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Property, plant and equipment | 7 | 6 | 6 | 6 | 7 | 7 | 7 | ||
| Intangible assets, net (including goodwill) | 0 | 2 | 2 | 2 | 0 | 1 | |||
| Goodwill | 0 | 0 | 0 | 0 | |||||
| Intangible assets, net (excluding goodwill) | 0 | 2 | 2 | 2 | 0 | 1 | |||
| Deposits noncurrent assets | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Other noncurrent assets | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||
| Other undisclosed noncurrent assets | 0 | 2 | 5 | ||||||
| Total noncurrent assets: | 8 | 6 | 8 | 9 | 9 | 9 | 13 | ||
| TOTAL ASSETS: | 85 | 96 | 31 | 35 | 31 | 25 | 33 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 12 | 5 | 4 | 5 | 4 | 3 | 2 | ||
| Accounts payable | 2 | 1 | 2 | 2 | 1 | 2 | 1 | ||
| Accrued liabilities | 9 | 3 | 2 | 3 | 2 | 2 | 1 | ||
| Employee-related liabilities | 1 | 1 | 1 | 1 | |||||
| Debt | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Due to related parties | 0 | ||||||||
| Other undisclosed current liabilities | 2 | 1 | 0 | 1 | |||||
| Total current liabilities: | 12 | 8 | 6 | 5 | 4 | 4 | 3 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 1 | 0 | 2 | 3 | 3 | 3 | 3 | ||
| Long-term debt, excluding current maturities | 0 | 2 | 3 | 3 | 3 | 3 | |||
| Finance lease, liability | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Operating lease, liability | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Liabilities, other than long-term debt | 1 | 0 | 0 | 0 | 0 | ||||
| Deferred revenue and credits | ✕ | ✕ | 0 | 0 | 0 | ||||
| Other liabilities | 1 | ||||||||
| Derivative instruments and hedges, liabilities | 0 | 0 | |||||||
| Other undisclosed noncurrent liabilities | 1 | 1 | 1 | 13 | 6 | ||||
| Total noncurrent liabilities: | 1 | 0 | 3 | 4 | 4 | 16 | 9 | ||
| Total liabilities: | 13 | 8 | 9 | 9 | 8 | 20 | 12 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | 71 | 88 | 22 | 26 | 23 | 2 | 19 | ||
| Preferred stock | 0 | ||||||||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Additional paid in capital | 57 | 52 | 50 | 50 | 43 | 29 | 29 | ||
| Retained earnings (accumulated deficit) | 15 | 36 | (28) | (23) | (19) | (28) | (10) | ||
| Other undisclosed stockholders' equity attributable to parent | 0 | ||||||||
| Other undisclosed stockholders' equity | 3 | 2 | |||||||
| Total stockholders' equity: | 71 | 88 | 22 | 26 | 23 | 5 | 21 | ||
| TOTAL LIABILITIES AND EQUITY: | 85 | 96 | 31 | 35 | 31 | 25 | 33 | ||
Income statement (P&L) ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 28 | 17 | 39 | 37 | 30 | 28 | 24 | |
| Revenue, net | ✕ | 17 | 39 | 37 | 30 | 28 | 24 | |
| Cost of revenue (Cost of Goods and Services Sold) | (9) | (6) | (19) | (19) | (17) | (19) | (14) | |
| Gross profit: | 19 | 11 | 20 | 18 | 13 | 9 | 9 | |
| Operating expenses | (40) | (24) | (25) | (22) | (20) | (23) | (21) | |
| Other operating expense, net | (0) | |||||||
| Other undisclosed operating income | 0 | 8 | 8 | |||||
| Operating loss: | (21) | (14) | (5) | (4) | (7) | (6) | (4) | |
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | 1 | 0 | 0 | (0) | 2 | (7) | (2) | |
| Interest and debt expense | (0) | (0) | ||||||
| Loss from continuing operations before equity method investments, income taxes: | (20) | (13) | (5) | (4) | (5) | (13) | (6) | |
| Other undisclosed income from continuing operations before income taxes | 0 | 0 | ||||||
| Loss from continuing operations before income taxes: | (20) | (13) | (5) | (4) | (5) | (13) | (6) | |
| Income tax expense (benefit) | 0 | 4 | 0 | (0) | (0) | (4) | (2) | |
| Net loss: | (20) | (9) | (5) | (4) | (5) | (17) | (8) | |
| Other undisclosed net income attributable to parent | 3 | |||||||
| Net loss attributable to parent: | (20) | (9) | (5) | (4) | (5) | (17) | (4) | |
| Other undisclosed net income (loss) available to common stockholders, basic | 74 | 14 | (1) | |||||
| Net income (loss) available to common stockholders, basic: | (20) | 64 | (5) | (4) | 8 | (18) | (4) | |
| Convertible preferred dividends | 1 | 1,061 | ||||||
| Other undisclosed net loss available to common stockholders, diluted | (0) | (0) | (3) | |||||
| Net income (loss) available to common stockholders, diluted: | (20) | 64 | (5) | (4) | 7 | 1,042 | (4) | |
Comprehensive Income ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (20) | (9) | (5) | (4) | (5) | (17) | (8) | |
| Comprehensive loss, net of tax, attributable to parent: | (20) | (9) | (5) | (4) | (5) | (17) | (8) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.